Cytomedix, Inc. is an autologous regenerative therapies company commercializing innovative platelet technologies for orthopedics and wound care with a pipeline of adult stem cell therapies for tissue repair. The Company markets the AutoloGel™ System, a device for the production of autologous platelet rich plasma ("PRP") gel for use on a variety of exuding wounds and the Angel® Concentrated Platelet Rich Plasma System, a blood processing device and disposable products used for the separation of whole blood or a mixture of blood and bone marrow, into red cells, platelet poor plasma ("PPP") and PRP in surgical settings On February 8, 2012 Cytomedix closed the acquisition of Aldagen, a biopharmaceutical company developing regenerative cell therapies based on its proprietary ALDH bright cell technology, currently in a Phase 2 trial for the treatment of ischemic stroke.
View Top Employees from Cytomedix Inc| Website | http://www.cytomedix.com |
| Revenue | $10 million |
| Employees | View employees |
| Founded | 2001 |
| Address | 207A PERRY Pkwy., Ste. 1, Gaithersburg, Maryland 20877, US |
| Phone | (240) 499-2680 |
| Fax | (240) 499-2690 |
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| Competitors | Capricor Therapeutics, Inc., Cesca Therapeutics Inc., Kolon TissueGene, Inc., Opexa Therapeutics, Regeneus Ltd |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 33 Companies, NAICS Code 3254 Companies, NAICS Code 339 Companies |
Looking for a particular Cytomedix Inc employee's phone or email?
Cytomedix Inc Questions
The Cytomedix Inc annual revenue was $10 million in 2023.
Cytomedix Inc is based in Gaithersburg, Maryland.
The NAICS codes for Cytomedix Inc are [32541, 325, 32, 33, 3254, 339].
The SIC codes for Cytomedix Inc are [28, 283].
